The adoption of linked data concepts from SMEs, meshed up with sophisticated analytics and visualization techniques within an integrated environment, called the LinDA Workbench, appears to reduce the effort for the realisation of specific tasks within the company, by almost 50% in terms of time, while at the same time, it supports the re-design of existing business processes and introduces increased efficiency and flexibility. In this paper, we briefly present the initial findings of the Business Intelligence Analytics (BIA) pilot operation of the LinDA project, which concerns the Over-The-Counter (OTC) medicines liberalisation in Europe. It aims at examining the association among the usage of OTC medicines and pharmaceutical parameters, with other healthcare, socio-economic and political ones. Focus is given on the added value emerged, through the consumption and production of linked data for analysis purposes, as well as the challenges faced for the execution of such a pilot.